
Aspira Women's Health AWH
Quartalsbericht 2025-Q3
hinzugefügt 14.11.2025
Aspira Women's Health ROE 2011-2026 | AWH
ROE Jährlich Aspira Women's Health
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -403.65 | -104.94 | -184.23 | -174.38 | -158.99 | -308.1 | -397.87 | -108.94 | -99.76 | -32.95 | -153.12 | -171.73 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -32.95 | -403.65 | -191.56 |
ROE Vierteljährlich Aspira Women's Health
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3482.46 | 3465.02 | 575.55 | 1289.66 | 1863.02 | 2206.67 | 357.53 | 287.91 | -495.84 | -993.03 | -170.62 | -195.83 | -151.41 | -108.15 | -51.63 | -95.74 | -114.64 | -138.95 | -121.66 | -165.38 | -164.98 | -174.94 | -135.61 | -172.7 | -166.06 | -159.32 | -119.56 | -193.2 | -229.77 | -256.4 | -221.37 | -313.77 | -332.52 | -362.91 | -322.22 | -351.55 | -288.48 | -216.46 | -80.54 | -109.58 | -109.29 | -110.5 | -78.59 | -87.24 | -66.85 | -45.91 | -26.16 | -69.46 | -104.12 | -138.51 | -123.66 | -168.55 | -170.15 | -183.0 | -141.47 | -44.9 | -55.15 | -41.42 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3482.46 | -993.03 | 79.1 |
ROE anderer Aktien in der Diagnostik & Forschung
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M | ||
|
Brainsway Ltd.
BWAY
|
-27.43 | $ 23.11 | 4.52 % | $ 99.4 M | ||
|
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | ||
|
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 23.0 | 2.86 % | $ 248 M | ||
|
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
-316.66 | $ 1.6 | -0.22 % | $ 2.03 M | ||
|
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M | ||
|
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
-41.08 | $ 6.1 | 1.16 % | $ 179 M | ||
|
Castle Biosciences
CSTL
|
4.0 | $ 39.93 | -1.67 % | $ 1.11 B | ||
|
Danaher Corporation
DHR
|
7.87 | $ 234.99 | -0.25 % | $ 172 B | ||
|
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | ||
|
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | ||
|
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | ||
|
DarioHealth Corp.
DRIO
|
-102.21 | $ 12.98 | 6.97 % | $ 368 M | ||
|
DexCom
DXCM
|
26.18 | $ 68.47 | -2.33 % | $ 26.4 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
-72.81 | $ 17.5 | -7.41 % | $ 941 M | ||
|
Celcuity
CELC
|
-96.68 | $ 105.54 | -3.33 % | $ 4.16 B | ||
|
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
-62.78 | $ 3.4 | 3.66 % | $ 108 K | ||
|
Exact Sciences Corporation
EXAS
|
-35.99 | $ 101.77 | 0.14 % | $ 18.9 B | ||
|
Fulgent Genetics
FLGT
|
-3.77 | $ 27.9 | -0.39 % | $ 844 M | ||
|
Guardant Health
GH
|
312.48 | $ 107.75 | -1.98 % | $ 13.2 B | ||
|
QIAGEN N.V.
QGEN
|
2.34 | $ 48.19 | 1.71 % | $ 10.7 B | ||
|
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
-51.54 | $ 146.41 | -2.48 % | $ 23.3 B | ||
|
Charles River Laboratories International
CRL
|
0.64 | $ 214.0 | -1.51 % | $ 11 B | ||
|
IQVIA Holdings
IQV
|
22.63 | $ 243.4 | -0.36 % | $ 44.1 B | ||
|
Quest Diagnostics Incorporated
DGX
|
12.85 | $ 177.06 | -0.64 % | $ 19.7 B | ||
|
Biodesix
BDSX
|
-205.65 | $ 5.77 | -3.27 % | $ 748 M | ||
|
Laboratory Corporation of America Holdings
LH
|
9.26 | $ 254.76 | 0.43 % | $ 21.4 B | ||
|
ICON Public Limited Company
ICLR
|
8.31 | $ 189.39 | -6.67 % | $ 15.6 B | ||
|
IDEXX Laboratories
IDXX
|
55.65 | $ 708.9 | -0.79 % | $ 58.5 B | ||
|
Lantheus Holdings
LNTH
|
28.72 | $ 68.27 | -1.59 % | $ 4.72 B | ||
|
Agilent Technologies
A
|
22.45 | $ 145.56 | -1.51 % | $ 44.3 B | ||
|
Biomerica
BMRA
|
-121.14 | $ 2.83 | 1.8 % | $ 6.5 M | ||
|
Bioventus
BVS
|
-90.0 | $ 8.0 | 5.12 % | $ 501 M | ||
|
Koninklijke Philips N.V.
PHG
|
9.97 | $ 29.47 | 1.25 % | $ 20 B | ||
|
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | ||
|
Precipio
PRPO
|
-40.56 | $ 23.85 | 2.49 % | $ 31 M | ||
|
Mettler-Toledo International
MTD
|
-680.23 | $ 1 461.94 | -0.56 % | $ 31 B | ||
|
Myriad Genetics
MYGN
|
-18.16 | $ 6.63 | -0.08 % | $ 601 M | ||
|
ENDRA Life Sciences
NDRA
|
-449.46 | $ 4.64 | 1.75 % | $ 2.49 M |